Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Health Ministry, Niti...

    Health Ministry, Niti Aayog are Favoring Pharma Firms, claims RSS affiliated outfit

    Written by savita thakur thakur Published On 2017-05-04T15:37:59+05:30  |  Updated On 4 May 2017 3:37 PM IST
    Health Ministry, Niti Aayog are Favoring Pharma Firms, claims RSS affiliated outfit

    New Delhi In a letter to PM Narendra Modi, the Swadeshi Jagran Manch (SJM), an outfit affiliated to the Rashtriya Swayamsevak Sangh (RSS) is reported to have blamed the Health Ministry and Niti Aayog for their secret involvement in the price ceiling activity.


    Writing to the Prime Minister Narendra Modi, SJM National Co-convenor Ashwani Mahajan said, “Your departments are acting against what you have promised (to) the people of India."


    “The pharmaceutical companies are making profits in the range of 500 per cent to 4000 per cent and that too after imposing price controls. This is because the current formula for arriving at a ceiling price is irrational that legitimises profiteering and is against the interests of the people,” the letter said.


    He further accused that under the influence of pharmaceutical companies, officials of the Ministries of Health, Commerce and Chemicals and Fertilisers were holding meetings with the NITI Aayog to dismantle the system of price control by trying to do away with the National Pharmaceuticals Pricing Authority (NPPA), which has the authority of ceiling prices of essential medicines


    He alleged, “Those in the government influenced by MNCs are trying to dismantle NPPA. The Niti Aayog has recommended dismantling of NPPA, and (also suggested) that there is no need for price regulation. Once it is dismantled, companies will be given a free hand.” In his letter, Mahajan alleged that the companies “could influence the Department of Pharmaceuticals (DoP), which changed the ceiling price formula." reports Express


    He wrote: “So powerful has the hold of the pharmaceutical companies (been) that secretaries and joint secretaries of three ministries – Health and Family Welfare, Commerce and Industry through DIPP (Department of Industrial Policy and Promotion), and Chemicals and Fertilisers through DoP – are now holding meetings with the Niti Aayog to completely dismantle the system of price control.” Mahajan alleged.


    He further claimed that Niti Aayog, "has a history of aligning with vested interests” to “dismantle the regime of price control."


    Department of PharmaceuticalsDOPHealth MinistryNational Pharmaceuticals Pricing AuthorityNiti AayogNPPAPharma Firmsprice ceilingRashtriya Swayamsevak SanghSwadeshi Jagran Manch
    Source : With inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok